SCHEMBL7144966

SCHEMBL7144966

COc1ccc(O)c([C@H](Nc2ccc(C#N)cc2)C(=O)NCc2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 1/20 0.43
SLC1A3 P43003 1/20 0.43
SLC1A2 P43004 1/20 0.43
RAB9A P51151 1/20 0.42
F2 P00734 4/20 0.42
PRSS1 P07477 4/20 0.42
F7 P08709 4/20 0.42
F10 P00742 3/20 0.42
TSHR P16473 1/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
MMP13 P45452 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7144961 1.00 ADRB3 (0.43) ADRB3SLC1A3SLC1A2RAB9AF2
SCHEMBL7140854 0.90 F7 (0.43) SLC1A3SLC1A2RAB9AF2PRSS1
SCHEMBL7140860 0.90 F7 (0.43) SLC1A3SLC1A2RAB9AF2PRSS1
SCHEMBL7142631 0.87 F2 (0.49) SLC1A3SLC1A2RAB9AF2PRSS1
SCHEMBL7142637 0.87 F2 (0.49) SLC1A3SLC1A2RAB9AF2PRSS1
SCHEMBL7150831 0.86 AKR1B1 (0.46) SLC1A3SLC1A2RAB9AF2PRSS1
SCHEMBL7147310 0.86 HPGD (0.43) SLC1A3SLC1A2RAB9AF2PRSS1
SCHEMBL7147306 0.86 HPGD (0.43) SLC1A3SLC1A2RAB9AF2PRSS1
SCHEMBL7146079 0.84 F7 (0.43) SLC1A3SLC1A2RAB9AF2PRSS1
SCHEMBL7146093 0.84 F7 (0.43) SLC1A3SLC1A2RAB9AF2PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0921116-B1 N-(4-carbamimido-phenyl)-glycine amide derivatives HOFFMANN LA ROCHE (CH) 2003-06-18 EP disclosed
US-6140353-A USED AS MEDICAMENTS FOR THE TREATMENT AND/OR PREVENTION OF THROMBOSES, APOPLEXY, CARDIAC INFARCTION, INFLAMMATION AND ARTERIOSCLEROSIS OR AS ANTITUMOR AGENTS HOFFMANN-LA ROCHE INC. (US) 2000-10-31 US disclosed
EP-0921116-A1 N-(4-carbamimido-phenyl)-glycine amide derivatives F. HOFFMANN-LA ROCHE AG (CH) 1999-06-09 EP disclosed